Registro:

Referencias:

• Bajorin, D., Chapman, P., Wong, G., Coit, D., Kunicka, J., Dimaggio, J., Cordon-Cardo, C., Houghton, A., Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma (1990) Cancer Res, 50, p. 7490
• Bover, L., Barrio, M., Slavutsky, I., Bravo, A.I., Quintans, C., Bagnati, A., Lema, B., Mordoh, J., Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor (1991) Breast Cancer Res Treat, 19, p. 47
• Chang, K., Pai, L., Batra, J., Pastan, I., Willingham, M., Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium (1992) Cancer Res, 52, p. 181
• Fogler, W., Sun, L., Klinger, M., Ghrayeb, J., Daddona, P., Biological characterization of a chimeric mouse-human IgM antibody directed against the 17-1A antigen (1989) Cancer Immunol Immunother, 30, p. 43
• Franker, P.J., Speck, J.C., Protein and cell membrane iodination with sparingly soluble chloramide 1,3,4,6-tetrachloro-3 a,6 a-diphenylglycouril (1978) Biochemical and Biophysical Research Communications, 80, p. 849
• Fujimori, K., Covell, D., Fletcher, J., Weinstein, J., Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')<inf>2</inf> and Fab in tumors (1989) Cancer Res, 49, p. 5656
• George, A., Spooner, R., Epenetos, A., Applications of monoclonal antibodies in clinical oncology (1994) Immunol Today, 15, p. 559
• Kaminski, M., Zasadny, K., Francis, I., Milik, A., Ross, C., Moon, S., Crawford, S., Wahl, R., Radioimmunotherapy of B-cell lymphoma with [131I] anti-B1 (anti-CD20) antibody (1993) N Engl J Med, 329, p. 459
• LoBuglio, A., Saleh, M., Lee, J., Khazaeli, M., Carrano, R., Holden, H., Wheeler, R., Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical Aspect (1988) J Natl Cancer Inst, 80, p. 932
• Mordoh, J., Chacón, R., Filmus, J., Isolation of tumor cells from patients with osteosarcoma and analysis of their sensitivity to methotrexate (1981) Cancer Res, 41, p. 3621
• Mordoh, J., Leis, S., Bravo, A.I., Podhajcer, O.L., Ballaré, C., Capurro, M., Kairiyama, C., Bover, L., Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias (1994) Int J Biol Markers, 9, p. 125
• Mordoh J, Silva C, Albarellos M, Bravo AI, Kairiyama C (1995) A phase I clinical trial in cancer patients of a new monoclonal antibody, FC-2.15, reacting with tumor proliferating cells J Immunother (in press); Morgan, A., Sullivan, W., Graves, S., Woodhouse, C., Murine monoclonal IgG3 to human colorectal tumor-associated antigens: enhancement of antibody-dependent cell-mediated cytotoxicity by interleukin 2 (1989) Cancer Res, 49, p. 2773
• Munn, D., Cheung, N., Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma (1987) Cancer Res, 47, p. 6600
• Nakamura, K., Koike, M., Shitara, K., Kuwana, Y., Kiuragi, K., Igarashi, S., Hasegawa, M., Hanai, N., Chimeric anti-ganglioside G<inf>M2</inf> antibody with antitumor activity (1994) Cancer Res, 54, p. 1511
• Neuberger, M., Rajewsky, K., Activation of mouse complement by monoclonal mouse antibodies (1981) Eur J Immunol, 11, p. 1012
• Nuti, M., Turchi, V., Masci, A.M., Viacava, P., Rughetti, A., Castagna, M., Frati, L., Characterization of monoclonal antibody 436 recognizing the Arg-Pro-Ala-Pro sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells (1992) Int J Biol Markers, 7, p. 71
• Orlandi, R., Figini, M., Tomassetti, A., Canevari, S., Colnaghi, M.I., Characterization of a mouse-human chimeric antibody to a cancer-associated antigen (1992) Int J Cancer, 52, p. 588
• Press, O., Hansen, J., Farr, A., Martin, P., Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes (1988) Cancer Res, 48, p. 2249
• Press, O., Eary, J., Appelbaum, F., Martin, P., Badger, C., Nelp, W., Glenn, S., Bernstein, I., Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support (1993) N Engl J Med, 329, p. 1219
• Pricop, L., Rabinowich, H., Morel, P., Sulica, A., Whiteside, T., Herberman, R., Characterization of the Fcμ receptor of human natural killer cells (1993) J Immunol, 151, p. 3018
• Riethmüller, G., Schneider-Gädicke, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Witte, J., Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma (1994) Lancet, 343, p. 1177. , the German Cancer Aid 17-1A Study Group
• Saleh, M., Khazaeli, M., Wheeler, R., Dropcho, E., Liu, T., Urist, M., Miller, D., LoBuglio, A., Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma (1992) Cancer Res, 52, p. 4342
• Saleh, M., Khazaeli, M., Grizzle, W., Wheeler, R., Lawson, S., Liu, T., Russell, C., LoBuglio, A., A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer (1993) Cancer Res, 53, p. 4555
• Scatchard, G., The attraction of proteins for small molecules and ions (1949) Annals of the New York Academy of Sciences, 51, p. 660
• Schlom, J., Eggensperger, D., Colcher, D., Molinolo, A., Houchens, D., Miller, L., Hinkle, G., Siler, K., Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates (1992) Cancer Res, 52, p. 1067
• Soule, H.D., Vazquez, J., Long, A., Albert, S., Brennan, M., A human cell line from a pleural effusion derived from a breast carcinoma (1973) J Natl Cancer Inst, 51, p. 1409
• Weinstein, J.N., Eger, R.R., Covell, D.G., Black, C.D.V., Mulshine, J., Carrasquillo, J.A., Larson, S.M., Keenan, A.M., The pharmacology of monoclonal antibodies (1987) Ann NY Acad Sci, 507, p. 199

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------